VREX
Varex Imaging Corporation · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | -1 | 16.05K | $296,388 | n/a | −1 |
| Q2 2026 | 73 | +1 | 23.53M | $245.80M | +4 | −3 |
| Q1 2026 | 74 | -2 | 23.68M | $251.27M | +5 | −7 |
| Q4 2025 | 76 | +1 | 25.15M | $293.07M | +1 | n/a |
| Q3 2025 | 16 | 0 | 13.89M | $172.28M | +1 | −1 |
| Q2 2025 | 13 | -1 | 12.33M | $106.93M | +1 | −2 |
| Q1 2025 | 11 | -1 | 6.63M | $76.87M | n/a | −1 |
| Q4 2024 | 12 | 0 | 6.74M | $98.34M | +1 | −1 |
| Q3 2024 | 11 | +1 | 5.38M | $64.17M | +3 | −2 |
| Q2 2024 | 10 | n/a | 2.74M | $40.40M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 924.79K | n/a | $13.63M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Millennium Management ✦ | 597.94K | n/a | $8.81M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 278.07K | n/a | $4.10M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | Two Sigma Investments ✦ | 257.06K | n/a | $3.79M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Renaissance Technologies ✦ | 239.20K | n/a | $3.52M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 163.23K | n/a | $2.40M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 152.80K | n/a | $2.25M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 84.03K | n/a | $1.24M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Bridgewater Associates ✦ | 33.19K | n/a | $488,948 | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 12.33K | n/a | $182,000 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 176 holders, 41.13M shares, $401.23M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 8.12K sh · $150,076
Officer · 130.00K sh · $2.40M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology